Inconsistent results in patients with sickle cell anemia, in which a poor outcome (i.e., number of recurrent VOC) seems to depend on high levels of IL-6, rather than CXCL8 [37], likely underline once more the heterogeneity of cerebrovascular diseases. This evidence concerns the gene CXCL8 and cerebrovascular disorder.